102839-00-9: Terazosin EP Impurity E (free base)
It is an impurity of Terazosin. Terazosin is a selective alpha-blocker, which is used in the treatment of benign prostatic hyperplasia.
Additional information on CAS 102839-00-9
Catalogue No.
VL4370003
CAS No.
102839-00-9
Molecular Formula
C₂₄H₂₈N₈O₄
Molecular Weight
492.53
Parent drug
Terazosin
IUPAC Name
2, 2'-(1, 4-Piperazinediyl)bis[6, 7-dimethoxy-4-quinazolinamine]
Synonyms
Terazosin Related Compound C; Prazosin EP Impurity E; Doxazosin EP Impurity H (free base); Terazosin Dimer Impurity; Terazosin EP Impurity E;
References
Sci-Hub, Long-term efficacy and safety of terazosin in patients with benign prostatic hyperplasia, 10.1016/s0090-4295(99)80008-9. (2022). Retrieved January 25, 2022, from Sci-hub.ee website: https://sci-hub.ee/10.1016/s0090-4295(99)80008-9
Status
In-stock
